ERIN MARTIN: Open Payments
NPI 1225311368 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 18 payments from 9 companies in 2025. Trend: 2023 $1,232 · 2024 $592 · 2025 $784
Food & beverage: $685Education: $99
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $243 |
| Janssen Biotech, Inc. | 3 | $157 |
| UCB, Inc. | 1 | $134 |
| Medtronic, Inc. | 2 | $122 |
| GENZYME CORPORATION | 1 | $35 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| Amgen Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, TREMFYA, Bimzelx, DUPIXENT, Zoryve, ILUMYA, OTEZLA, NEMLUVIO.
Industry payments across IN — which companies pay providers there.
